BSPED2014 Poster Presentations (1) (88 abstracts)
Three year experience of a national interdisciplinary initiative to improve outcomes for children with hypothalamic pituitary axis tumours (HPATs) using multi-site videoconferencing for decision making on Behalf of the UK HPAT Interest Group
Paul Morillon 1 , Daniel Perelberg 1 , Laura Losa 2 , Ash Ederies 2 , Kristan Aquilina 2 , Neil Dorward 3 , Anton Michalski 2 , Darren Hargrave 2 , Yen-Ching Chang 3 , Niloofar Bozorgi 2 , Samantha James 2 , Marta Korbontis 4 , William Drake 4 , Scott Akker 4 , Connor Mallucci 5 , Barry Pizer 5 , Jo Blair 5 , Ian Kamaly 6 , Peter Clayton 6 & Helen Spoudeas 2
1University College London, London, UK; 2Great Ormond Street Hospital, London, UK; 3University College London Hospitals, London, UK; 4St Bartholomew’s Hospital, London, UK; 5Alder Hey Children’s Hospital, Liverpool, UK; 6Royal Manchester Children’s Hospital, Manchester, UK.
Background: Childhood tumours of the hypothalamic pituitary axis (HPATs) are very rare and hence any single centre experience is limited. Without evidence-based guidance, treatment is individualised on a case basis. Survival rates are high, but at the expense of significant morbidity. Centralised care or wider multi-professional consultation may improve neuroendocrine and visual outcomes.
Objective and hypotheses: 1. To facilitate multi-professional dialogue across centres nationally (including adult pituitary specialists) in a videoconference format.
2. To enhance diagnostic and treatment decision making through education and sharing audits, knowledge and experience.
Method: From April to October 2011, a live, monthly videoconference was piloted across three sites. Pituitary physicians and surgeons, paediatric neurooncologists, neuroradiologists, neurosurgeons, neuropathologists and clinical oncologists all contributed. Having overcome initial technical limitations, monthly meetings continued over the next 2 years.
Results: In 27 meetings spanning 2.5 years, the clinical cases (including quality imaging) of 67 HPAT patients were discussed in relation to formulating management plans. Of these, 16 were discussed on multiple occasions. Of the 67 cases, craniopharyngiomas (17) were the most common tumour type. In addition, three guest lectures and five new audits of centre experience in craniopharyngiomas (3), prolactinomas (1) and suprasellar gliomas (1) were presented. To date, there are seven participating centres, increased attendees and 3–4 case discussions per month, even attracting international participation from centres in Ireland and Australia.
Conclusion: A national, regular, multidisciplinary consultation for discussing rare HPATs is feasible and welcomed, facilitating dialogue amongst a wide specialist professional grouping and influencing management. With appropriate funding, such collaborative experience with outcome monitoring, regular on-going audits and an educational programme should enhance the management of this rare group of patients, resulting in better outcomes and shaping the national standard of care.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more